Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s141, 2023. DOI: 10.25251/skin.7.supp.141. Disponível em: https://skin.dermsquared.com/skin/article/view/2024. Acesso em: 20 apr. 2026.